Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
advocated, Amy, Andreatta, antagonize, authoritative, barzolvolimab, bidding, branch, BTK, bulk, Chevron, China, Chinese, closeout, collateralized, compensatory, complement, conflict, cutting, Dolca, driver, duly, East, epitope, erythema, evidenced, exhibit, extracellular, female, Florida, Geopolitical, Graham, herewith, highlighting, identification, immunologically, implicated, Indiana, Inline, intradermally, Iowa, IRA, JAK, kinase, Ladd, Linkbase, MAD, marketplace, MAVERICK, monocyte, Montana, Neil, omitted, ordinary, Oregon, outweigh, POC, pre, proud, Rand, ratifying, retaliation, SAD, signature, software, stead, Steven, Sutherland, SYK, Taxonomy, Tennessee, thereunto, therewith, thing, thousand, true, tyrosine, unconstitutional, undermine, undersigned, undeterminable, virtue, vital, warrant, Washington, worth, XBRL
Removed:
absence, acceptability, ADCC, AG, aggregating, Aldeyra, appealed, AstraZeneca, avidity, baseline, behavior, benralizumab, bind, BioWa, bivalent, Blueprint, Bristol, Ch, characterization, CMO, colon, commented, comorbid, Composite, concomitant, Concurrently, confusion, consisting, converted, correlated, cytokine, cytotoxicity, dated, degranulation, Del, deplete, dermal, dermographism, destroying, digit, discontinued, dual, duodenum, EGID, elevated, endorse, enrolled, EoE, eosinophilia, ergometry, exercisable, Falk, Fc, February, feeling, fenebrutinib, fibrotic, Finally, flushing, Fric, Genentech, graph, grouping, headache, Henrik, Importantly, inclusive, ineligible, informative, injection, intravenously, introducing, IRR, irrespective, isolated, itch, Japan, JHU, jointly, KD, killer, language, lesser, Lonza, mammalian, Matthew, mg, mild, minimal, moderate, mucosal, naturally, nausea, NK, nomenclature, nonexclusive, observe, offsetting, Pfizer, Pharma, pharmacokinetic, placement, plaintiff, plasmon, pM, poorly, prolonged, prompt, pulse, questionnaire, ranging, Rasmussen, recruited, reinvestment, remove, removing, reservation, resonance, respiratory, resume, ruling, SAC, Salzberg, Sciabacucchi, score, Shire, spend, Squibb, stomach, sublicense, subtype, syndrome, Temporal, terminating, terminology, topical, translate, tripartite, UCT, uncommon, uncontrolled, unexpired, University, Varied, view
Filing tables
Filing exhibits
Related press release
ALLK similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1)
Registration Statements (Form S-8 No. 333-226247, 333-231276, 333-236631, 333-253701, 333-262749, 333-269134 and 333-276392) pertaining to the 2018 Equity Incentive Plan, the 2018 Employee Stock Purchase Plan and the amended 2012 Equity Incentive Plan of Allakos Inc., and
(2)
Registration Statements (Form S-3 No.333-265085 and 333-275517) of Allakos Inc.,
of our report dated March 14, 2024, with respect to the financial statements of Allakos Inc., included in this Annual Report (Form 10-K) of Allakos Inc. for the year ended December 31, 2023.
/s/ Ernst & Young LLP
San Mateo, California
March 14, 2024